HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Maintains $24 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Andrew Fein maintains a Buy rating on Vigil Neuroscience (NASDAQ:VIGL) and keeps the price target at $24.
March 27, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Andrew Fein maintains a Buy rating on Vigil Neuroscience with a $24 price target.
The reiteration of a Buy rating and a $24 price target by a reputable analyst suggests a positive outlook for Vigil Neuroscience, likely leading to increased investor confidence and potential upward movement in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100